Jamaica Plain, MA, United States of America

Carson C Thoreen


 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Carson C Thoreen: Innovator in mTOR Complexes

Introduction

Carson C Thoreen is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of small molecule modulators for mTOR complexes. With a total of 2 patents, his work focuses on addressing various proliferative and metabolic diseases.

Latest Patents

Thoreen's latest patents include innovations related to soluble mTOR complexes and modulators thereof. These inventions pertain to small molecule modulators of mTORC1 and mTORC2, which are crucial in the treatment of proliferative diseases such as cancers, inflammatory diseases, autoimmune diseases, and diabetic retinopathy. His patents provide novel small molecules that inhibit mTORC1, mTORC2, and PI3K-related proteins. Additionally, he discusses methods for providing soluble mTORC1 and mTORC2 complexes, as well as high-throughput screening methods for identifying inhibitory compounds.

Career Highlights

Throughout his career, Carson C Thoreen has worked with prestigious institutions, including the Dana-Farber Cancer Institute and the Whitehead Institute for Biomedical Research. His research has significantly advanced the understanding of mTOR signaling pathways and their implications in various diseases.

Collaborations

Thoreen has collaborated with esteemed colleagues such as Nathanael Schiander Gray and Jae Won Chang. These partnerships have further enriched his research and contributed to the development of innovative solutions in the biomedical field.

Conclusion

Carson C Thoreen's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of critical health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…